• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米乳剂用于靶向神经退行性疾病:阿尔茨海默病、帕金森病和朊病毒病。

Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's.

机构信息

Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Deemed to be University, Mumbai 400 056, India.

Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Deemed to be University, Mumbai 400 056, India.

出版信息

Life Sci. 2020 Mar 15;245:117394. doi: 10.1016/j.lfs.2020.117394. Epub 2020 Feb 1.

DOI:10.1016/j.lfs.2020.117394
PMID:32017870
Abstract

Neurodegenerative diseases need the drugs to be delivered right inside the brain to maximizing the therapeutic effects. This can be achieved by use of novel targeted delivery systems such as nanoemulsions. Nanoemulsions (NE) are nano-sized emulsions that are manufactured for enhancing the delivery of drugs to the targeted site and minimize adverse effects and toxic reactions. Looking into the advanced pharmaceutical applications of NE, the present review gives an insight to the understanding of the application of NE in NDs like AD, PD and Prion's disease. The review also touches upon the pathophysiology of these ND diseases to have a clear understanding of the molecular aspects of the disease. Finally, the review sets a standpoint of nanoemulsion's significance in the treatment therapy of ND besides the drawbacks associated with the current drug therapy in NDs.

摘要

神经退行性疾病需要将药物直接递送到大脑内部,以最大限度地提高治疗效果。这可以通过使用新型靶向递药系统如纳米乳剂来实现。纳米乳剂(NE)是纳米级乳剂,用于增强药物递送到靶向部位,并最小化不良反应和毒性反应。本文着眼于 NE 在药物制剂中的应用,深入了解了 NE 在神经退行性疾病(如 AD、PD 和朊病毒病)中的应用。本文还涉及这些 ND 疾病的病理生理学,以便更清楚地了解疾病的分子方面。最后,本文除了讨论与 ND 目前药物治疗相关的缺点外,还从纳米乳剂在 ND 治疗中的意义方面进行了评价。

相似文献

1
Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's.纳米乳剂用于靶向神经退行性疾病:阿尔茨海默病、帕金森病和朊病毒病。
Life Sci. 2020 Mar 15;245:117394. doi: 10.1016/j.lfs.2020.117394. Epub 2020 Feb 1.
2
Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.淀粉样寡聚物的结构及其毒性机制:利用新型治疗方法靶向淀粉样寡聚物。
Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2.
3
Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.用于治疗阿尔茨海默病和帕金森病的纳米医学进展。
Nanomedicine (Lond). 2016 May;11(10):1267-85. doi: 10.2217/nnm-2016-0019. Epub 2016 Apr 14.
4
Nanotechnological applications for the treatment of neurodegenerative disorders.用于治疗神经退行性疾病的纳米技术应用。
Prog Neurobiol. 2009 Aug;88(4):272-85. doi: 10.1016/j.pneurobio.2009.05.002. Epub 2009 May 30.
5
Nanomedicine against Alzheimer's and Parkinson's Disease.纳米医学治疗阿尔茨海默病和帕金森病。
Curr Pharm Des. 2021;27(12):1507-1545. doi: 10.2174/1381612826666201021140904.
6
Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.阿尔茨海默病和帕金森病:采用纳米技术方法的当前治疗综述。
Curr Pharm Des. 2018;24(1):22-45. doi: 10.2174/1381612823666170828133059.
7
Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer's disease.纳米乳剂作为靶向阿尔茨海默病的可行载体的治疗潜力。
Drug Discov Today. 2021 Dec;26(12):2881-2888. doi: 10.1016/j.drudis.2021.07.020. Epub 2021 Jul 29.
8
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.靶向中枢神经系统:从合成纳米颗粒到细胞外囊泡——聚焦阿尔茨海默病和帕金森病。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1898. doi: 10.1002/wnan.1898. Epub 2023 May 8.
9
Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.通过药物递送系统治疗阿尔茨海默病和帕金森病的策略
Curr Med Chem. 2016;23(31):3618-3631. doi: 10.2174/0929867323666160824162401.
10
The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.铁转运体和调节蛋白在阿尔茨海默病和帕金森病中的作用:病理生理学见解和治疗前景。
Biomed Pharmacother. 2024 Oct;179:117419. doi: 10.1016/j.biopha.2024.117419. Epub 2024 Sep 8.

引用本文的文献

1
Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer's disease.基于植物的类黄酮及其纳米颗粒:对抗阿尔茨海默病的最新武器。
Drug Deliv Transl Res. 2025 Jun 30. doi: 10.1007/s13346-025-01906-9.
2
Emerging nano-derived therapy for the treatment of dementia: a comprehensive review.新兴的纳米衍生疗法治疗痴呆症:综述
Drug Deliv Transl Res. 2025 Apr 23. doi: 10.1007/s13346-025-01863-3.
3
Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes.
纳米技术在缺血性中风中的作用:靶向治疗与诊断的进展以改善临床结局
J Funct Biomater. 2025 Jan 1;16(1):8. doi: 10.3390/jfb16010008.
4
Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease.载有药物组合的纳米载体在治疗阿尔茨海默病中的前瞻性应用。
Curr Pharm Des. 2025;31(18):1444-1460. doi: 10.2174/0113816128348877241202053633.
5
A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson's Disease: An Updated Patent and Clinical Trials.纳米载体用于治疗帕金森病的再利用综合综述:最新专利与临床试验
CNS Neurol Disord Drug Targets. 2025;24(3):181-195. doi: 10.2174/0118715273323074241001071645.
6
Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.阿尔茨海默病治疗的最新观点:血脑屏障和基于抗氧化剂的药物传递系统的作用。
Molecules. 2024 Aug 27;29(17):4056. doi: 10.3390/molecules29174056.
7
Nanotechnology-driven Microemulsion Based Intranasal Delivery to Neurotechnology-driven Neuralink: Strategies to Improve Management of Neurodegenerative Disorders.纳米技术驱动的微乳液经鼻给药向神经技术驱动的 Neuralink:改善神经退行性疾病管理的策略。
AAPS PharmSciTech. 2024 Sep 12;25(7):215. doi: 10.1208/s12249-024-02929-0.
8
Current Overview on the Use of Nanosized Drug Delivery Systems in the Treatment of Neurodegenerative Diseases.纳米药物递送系统在神经退行性疾病治疗中的应用现状综述
ACS Omega. 2024 Aug 5;9(33):35223-35242. doi: 10.1021/acsomega.4c01774. eCollection 2024 Aug 20.
9
The Therapeutic Potential of and and Advances in Nutraceutical Delivery Systems in Neurodegenerative Diseases.[具体物质名称]和[具体物质名称]的治疗潜力以及神经退行性疾病中营养保健品递送系统的进展。 (你提供的原文中“and”前后内容缺失,请补充完整以便准确翻译)
Pharmaceuticals (Basel). 2024 May 20;17(5):660. doi: 10.3390/ph17050660.
10
In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification.用于神经退行性疾病的体内和体外基因治疗:疾病修饰的希望。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7501-7530. doi: 10.1007/s00210-024-03141-4. Epub 2024 May 22.